240 related articles for article (PubMed ID: 21189248)
1. Oncogenic activity of Ect2 is regulated through protein kinase C iota-mediated phosphorylation.
Justilien V; Jameison L; Der CJ; Rossman KL; Fields AP
J Biol Chem; 2011 Mar; 286(10):8149-8157. PubMed ID: 21189248
[TBL] [Abstract][Full Text] [Related]
2. Ect2 links the PKCiota-Par6alpha complex to Rac1 activation and cellular transformation.
Justilien V; Fields AP
Oncogene; 2009 Oct; 28(41):3597-607. PubMed ID: 19617897
[TBL] [Abstract][Full Text] [Related]
3. Protein kinase Cι promotes UBF1-ECT2 binding on ribosomal DNA to drive rRNA synthesis and transformed growth of non-small-cell lung cancer cells.
Justilien V; Lewis KC; Meneses KM; Jamieson L; Murray NR; Fields AP
J Biol Chem; 2020 Jun; 295(24):8214-8226. PubMed ID: 32350115
[TBL] [Abstract][Full Text] [Related]
4. Matrix metalloproteinase-10 is a critical effector of protein kinase Ciota-Par6alpha-mediated lung cancer.
Frederick LA; Matthews JA; Jamieson L; Justilien V; Thompson EA; Radisky DC; Fields AP
Oncogene; 2008 Aug; 27(35):4841-53. PubMed ID: 18427549
[TBL] [Abstract][Full Text] [Related]
5. A novel small-molecule inhibitor of protein kinase Ciota blocks transformed growth of non-small-cell lung cancer cells.
Stallings-Mann M; Jamieson L; Regala RP; Weems C; Murray NR; Fields AP
Cancer Res; 2006 Feb; 66(3):1767-74. PubMed ID: 16452237
[TBL] [Abstract][Full Text] [Related]
6. Protein kinase Ciota is required for pancreatic cancer cell transformed growth and tumorigenesis.
Scotti ML; Bamlet WR; Smyrk TC; Fields AP; Murray NR
Cancer Res; 2010 Mar; 70(5):2064-74. PubMed ID: 20179210
[TBL] [Abstract][Full Text] [Related]
7. Atypical protein kinase Ciota plays a critical role in human lung cancer cell growth and tumorigenicity.
Regala RP; Weems C; Jamieson L; Copland JA; Thompson EA; Fields AP
J Biol Chem; 2005 Sep; 280(35):31109-15. PubMed ID: 15994303
[TBL] [Abstract][Full Text] [Related]
8. Meta-analysis of oncogenic protein kinase Ciota signaling in lung adenocarcinoma.
Erdogan E; Klee EW; Thompson EA; Fields AP
Clin Cancer Res; 2009 Mar; 15(5):1527-33. PubMed ID: 19223491
[TBL] [Abstract][Full Text] [Related]
9. Chromosome 3q26 Gain Is an Early Event Driving Coordinated Overexpression of the PRKCI, SOX2, and ECT2 Oncogenes in Lung Squamous Cell Carcinoma.
Liu Y; Yin N; Wang X; Khoor A; Sambandam V; Ghosh AB; Fields ZA; Murray NR; Justilien V; Fields AP
Cell Rep; 2020 Jan; 30(3):771-782.e6. PubMed ID: 31968252
[TBL] [Abstract][Full Text] [Related]
10. Aurothiomalate inhibits transformed growth by targeting the PB1 domain of protein kinase Ciota.
Erdogan E; Lamark T; Stallings-Mann M; Lee Jamieson ; Pellecchia M; Thompson EA; Johansen T; Fields AP
J Biol Chem; 2006 Sep; 281(38):28450-9. PubMed ID: 16861740
[TBL] [Abstract][Full Text] [Related]
11. Atypical protein kinase C phosphorylates Par6 and facilitates transforming growth factor β-induced epithelial-to-mesenchymal transition.
Gunaratne A; Thai BL; Di Guglielmo GM
Mol Cell Biol; 2013 Mar; 33(5):874-86. PubMed ID: 23249950
[TBL] [Abstract][Full Text] [Related]
12. A small molecule inhibitor of atypical protein kinase C signaling inhibits pancreatic cancer cell transformed growth and invasion.
Butler AM; Scotti Buzhardt ML; Erdogan E; Li S; Inman KS; Fields AP; Murray NR
Oncotarget; 2015 Jun; 6(17):15297-310. PubMed ID: 25915428
[TBL] [Abstract][Full Text] [Related]
13. Oncogenic Ect2 signaling regulates rRNA synthesis in NSCLC.
Justilien V; Lewis KC; Murray NR; Fields AP
Small GTPases; 2019 Sep; 10(5):388-394. PubMed ID: 28657426
[TBL] [Abstract][Full Text] [Related]
14. The oncogenic role of PKCiota gene amplification and overexpression in Chinese non-small cell lung cancer.
Luo Q; Tang L; Lin H; Huang J; Zhang T; Liu Y; Wang J; Zhan P; Yin X; Su X; Ji Q; Yu D; Xu L
Lung Cancer; 2014 May; 84(2):190-5. PubMed ID: 24636699
[TBL] [Abstract][Full Text] [Related]
15. Atypical protein kinase C iota is an oncogene in human non-small cell lung cancer.
Regala RP; Weems C; Jamieson L; Khoor A; Edell ES; Lohse CM; Fields AP
Cancer Res; 2005 Oct; 65(19):8905-11. PubMed ID: 16204062
[TBL] [Abstract][Full Text] [Related]
16. Recurrent copy number gains drive PKCι expression and PKCι-dependent oncogenic signaling in human cancers.
Liu Y; Justilien V; Fields AP; Murray NR
Adv Biol Regul; 2020 Dec; 78():100754. PubMed ID: 32992230
[TBL] [Abstract][Full Text] [Related]
17. Nucleotide exchange factor ECT2 interacts with the polarity protein complex Par6/Par3/protein kinase Czeta (PKCzeta) and regulates PKCzeta activity.
Liu XF; Ishida H; Raziuddin R; Miki T
Mol Cell Biol; 2004 Aug; 24(15):6665-75. PubMed ID: 15254234
[TBL] [Abstract][Full Text] [Related]
18. Protein kinase Ciota is required for Ras transformation and colon carcinogenesis in vivo.
Murray NR; Jamieson L; Yu W; Zhang J; Gökmen-Polar Y; Sier D; Anastasiadis P; Gatalica Z; Thompson EA; Fields AP
J Cell Biol; 2004 Mar; 164(6):797-802. PubMed ID: 15024028
[TBL] [Abstract][Full Text] [Related]
19. Targeting the oncogenic protein kinase Ciota signalling pathway for the treatment of cancer.
Fields AP; Frederick LA; Regala RP
Biochem Soc Trans; 2007 Nov; 35(Pt 5):996-1000. PubMed ID: 17956262
[TBL] [Abstract][Full Text] [Related]
20. PKCι regulates nuclear YAP1 localization and ovarian cancer tumorigenesis.
Wang Y; Justilien V; Brennan KI; Jamieson L; Murray NR; Fields AP
Oncogene; 2017 Jan; 36(4):534-545. PubMed ID: 27321186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]